- Record: found
- Abstract: found
- Article: not found
Capecitabine as adjuvant treatment for stage III colon cancer.
Chris Twelves
1 ,
Alfred Wong ,
Marek P Nowacki ,
Markus Abt ,
Howard Burris ,
Alfredo Carrato ,
Jim Cassidy ,
Andrés Cervantes ,
Jan Fagerberg ,
Vassilis Georgoulias ,
Fares Husseini ,
Duncan Jodrell ,
Piotr Koralewski ,
Hendrik Kröning ,
Jean Maroun ,
Norbert Marschner ,
Joseph McKendrick ,
Marek Pawlicki ,
Riccardo Rosso ,
Johannes Schüller ,
Jean-François Seitz ,
Borut Stabuc ,
Jerzy Tujakowski ,
Guy Van Hazel ,
Jerzy Zaluski ,
Werner Scheithauer
Jun 30 2005
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant treatment for colon cancer. The oral fluoropyrimidine capecitabine is an established alternative to bolus fluorouracil plus leucovorin as first-line treatment for metastatic colorectal cancer. We evaluated capecitabine in the adjuvant setting.